456663697
19 Sep 2020
United States ImmunoGen Presents Final Data From Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination With Carboplatin and Avastin at ESMO, United states
N/A
Healthcare & Medical - Health services Tenders , Healthcare and Medical Tenders
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.